 |
|
Genetic analysis helps dissect molecular basis of cardiovascular disease
November 23, 2009Common genetic contributions to plasma lipoprotein profile determined by large scale, genome-wide genetic analysis
Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study. This large scale analysis of the effects of common genetic variation on plasma lipoprotein profile, a critical component of cardiovascular risk, identified 43 genetic loci contributing to lipoprotein metabolism, including 10 loci not previously recognized in other whole genome analyses. The findings are published on November 20 in the open-access journal PLoS Genetics.
The findings were validated among additional populations of both men and women. The research also quantifies the contribution of common genetic variation to the concentration of plasma lipoproteins according to class, that is low-density lipoprotein (LDL), high-density lipoprotein (HDL), or very low density lipoprotein (VLDL), as well as size and cholesterol or triglyceride content.
The balance of LDL, HDL, and VLDL particle concentration is firmly established as a measure of cardiovascular risk. These major classes of lipoprotein particles are composed of sub-species that can be categorized according to size. While the overall concentration of each of the major classes can be estimated by the clinical measures of LDL-cholesterol, HDL-cholesterol, and triglycerides, the determinations of the concentration of the sub-species by NMR methodology in the current study provide a more precise picture of lipoprotein profile. Clinical research is engaged in determining the contribution of each of the sub-species to cardiovascular risk.
"This current genetic analysis complements clinical analysis of cardiovascular risk by evaluating the genetic contribution to the concentration of each lipoprotein sub-species and helps to delineate genes and metabolic pathways that might be targeted for interventional strategies," noted Dr. Chasman. He continued "the research can be placed in the larger context of studies that are leveraging knowledge of the human genome to dissect the molecular basis of common diseases, particularly cardiovascular disease, through large scale, genome-wide genetic analysis."
Public Library of Science
The balance of LDL, HDL, and VLDL particle concentration is firmly established as a measure of cardiovascular risk. These major classes of lipoprotein particles are composed of sub-species that can be categorized according to size. While the overall concentration of each of the major classes can be estimated by the clinical measures of LDL-cholesterol, HDL-cholesterol, and triglycerides, the determinations of the concentration of the sub-species by NMR methodology in the current study provide a more precise picture of lipoprotein profile. Clinical research is engaged in determining the contribution of each of the sub-species to cardiovascular risk.
"This current genetic analysis complements clinical analysis of cardiovascular risk by evaluating the genetic contribution to the concentration of each lipoprotein sub-species and helps to delineate genes and metabolic pathways that might be targeted for interventional strategies," noted Dr. Chasman. He continued "the research can be placed in the larger context of studies that are leveraging knowledge of the human genome to dissect the molecular basis of common diseases, particularly cardiovascular disease, through large scale, genome-wide genetic analysis."
Public Library of Science
Lipoprotein Current Events and Lipoprotein News RSSLow Cholesterol Transfer Protein Activity Associated with Heart Disease Risk
Although seen as a potential heart disease therapy, raising high-density lipoprotein (HDL) cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests.
New research identifies modifiable risk factors for heart disease
Emerging research on cardiovascular risk factors and treatment effects are helping clinicians gain a better understanding of which patients are most likely to benefit from close monitoring, lifestyle changes and/or additional therapeutic interventions.
Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find
Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many bacteria must be present to start the process.
Adding ezetimibe to atorvastatin improves lipid control
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone.
Metabolic syndrome linked to liver disease in obese teenaged boys
Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease.
Lead in bone associated with increased risk of death from cardiovascular disease in men
Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension.
UCLA scientists uncover immune system's role in bone loss
Got high cholesterol? You might want to consider a bone density test. A new UCLA study sheds light on the link between high cholesterol and osteoporosis and identifies a new way that the body's immune cells play a role in bone loss.
More patients across the world lowering 'bad' cholesterol
The percentage of patients lowering their elevated "bad" cholesterol to within target levels nearly doubled in the last decade, according to a multi-national survey reported in Circulation: Journal of the American Heart Association.
Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis
Undertaking a supervised exercise programme can have beneficial effects on functional status and physical function, reduce the need for daily corticosteroid and anti-inflammatory intake and improve levels of depression and anxiety in people with rheumatoid arthritis (RA).
Hormone therapy plus physical activity reduce belly fat, body fat percentage after menopause
Older women who take hormone therapy to relieve menopausal symptoms may get the added benefit of reduced body fat if they are physically active, according to a new study.
More Lipoprotein Current Events and Lipoprotein News Articles
 |
Biochemistry of Lipids, Lipoproteins and Membranes, Fifth Edition (New Comprehensive Biochemistry) by J.E. Vance (Editor), Dennis E. Vance (Editor) Research on the biochemistry and molecular biology of lipids and lipoproteins has experienced remarkable growth in the last 20 years, particularly with the realization that many different classes of lipids play fundamental roles in diseases such as heart disease, obesity, diabetes, cancer and neurodegenerative disorders. The 5th edition of this book has been written with two major objectives. The first objective is to provide students and teachers with an advanced up-to-date textbook covering the major areas of current interest in the lipid field. The chapters are written for students and researchers familiar with the general concepts of lipid metabolism but who wish to expand their knowledge in this area. The second objective is to provide a reference text for scientists who are about... |
|
Lipid and Lipoprotein Disorders : Current Clinical Soluti on by International Guidelines Cntr | |
 |
Source Naturals Policosanol Cholesterol Complex, Tablets, 90 tablets by Source Naturals Dietary supplement. Bio Align. Policosanol Cholesterol Complex, part of the Cholesterol Rescue family of products, is a Bio-Aligned formula that supports cholesterol wellness by helping to maintain multiple interdependent body organs and systems; heart, blood vessels, nervous system, thyroid, liver and gastrointestinal tract. (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.) |
 |
Lipoproteins, Apolipoproteins, and Lipases, Volume 45 (Advances in Protein Chemistry) by Verne N. Schumaker (Editor), Christian B. Anfinsen (Editor), John T. Edsall (Editor), Frederic M. Richards (Editor), David S. Eisenberg (Editor) This volume contains eight chapters that present both new and reviewed information fundamental to a clear understanding of lipid catabolism and transport at the molecular level. Three-dimensional structures of important serum lipoproteins, apolipoproteins, and lipases, utilizing X-ray data when available, are emphasized, and an attempt is made to relate structures to function. Key Features * Amphipathic helix * Apolipoprotein E * Lipophorin * Structure of serum albumin * Lipid binding proteins * Apolipoprotein B * Low-density lipoprotein |
 |
Cholesterol: Raising the Good and Lowering the Bad (Home Use) By now, most people have heard the term HDL - good cholesterol, and LDL - bad cholesterol. But do you know what makes good cholesterol good and bad cholesterol bad? And how does the wrong combination of these lipoproteins affect the risk of heart disease? This program will delve into these important questions and provide you with the answers you need to control your cholesterol. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
High Cholesterol Paper Paper Unmounted by Anatomical Chart Company |
 |
Lipid and Lipoprotein Disorders (PocketGuides (International Guidelines Center)) by MD, FAHA, FNLA William Cromwell (Author), FACP, FNLA Thomas Dayspring MD (Author), MD, FACS, FCCP Michael F. Richman (Author) The Guidelines PocketGuide is a spiral-bound pocket guide containing society-endorsed evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students. The Lipid and Lipoprotein Disorders: Current Clinical Solutions PocketGuide is a practical quick-reference tool containing screening, diagnostic, treatment algorithm, drug therapy, dosing information, patient monitoring, and counseling points. It provides all that is needed to make accurate clinical decisions at the point of care including lipid/lipoprotein physiology and definitions, major cardiovascular risk factors, risk factors associated with the metabolic syndrome estimate of ten-year risk for men and women, current medication... |
 |
Nature's Life - Cranberry Concentrate- 1200mg 60ct Tab by Nature's Life Low pH Enhances inhibit bacteria growth in urinary tract* |
 |
Lipoprotein Protocols (Methods in Molecular Biology) by Jose M. Ordovas (Editor) Tufts Univ., Boston, MA. Presents a set of molecular biology and protein techniques designed for use in the laboratory. Focuses on the practical aspects of the methods, including solving problems. Halftone illustrations. Outline format. |
|
Blood lipids and lipoproteins: quantitation, composition, and metabolism by Gary J Nelson (Author) |
| © 2010 BrightSurf.com |